Jason A. Deck

Array ( [id] => 9427695 [patent_doc_number] => 08703770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Pyridazine carboxamide orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/126654 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15727 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290314 [patent_doc_number] => 20120178638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'RNA MONOMERS CONTAINING O-ACETAL LEVULINYL ESTER GROUPS AND THEIR USE IN RNA MICROARRAYS' [patent_app_type] => utility [patent_app_number] => 13/061022 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26959 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071273 [patent_doc_number] => 20110046124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Bait Spray for Controlling Ant Populations' [patent_app_type] => utility [patent_app_number] => 12/922796 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2017 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046124.pdf [firstpage_image] =>[orig_patent_app_number] => 12922796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502053 [patent_doc_number] => 20110263718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'PROCESS FOR THE PREPARATION OF O-DESMETHYLVENLAFAXINE' [patent_app_type] => utility [patent_app_number] => 13/056025 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6140 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263718.pdf [firstpage_image] =>[orig_patent_app_number] => 13056025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663740 [patent_doc_number] => 20110313009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/054456 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15590 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313009.pdf [firstpage_image] =>[orig_patent_app_number] => 13054456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055840 [patent_doc_number] => 20110112200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'SOLID STATES OF O-DESMETHYLVENLAFAXINE SALTS' [patent_app_type] => utility [patent_app_number] => 12/991069 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7161 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112200.pdf [firstpage_image] =>[orig_patent_app_number] => 12991069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944995 [patent_doc_number] => 20110105615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'TABLET QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND METHOD FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/997779 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6849 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105615.pdf [firstpage_image] =>[orig_patent_app_number] => 12997779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9621084 [patent_doc_number] => 08791258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Pro-fluorescent probes' [patent_app_type] => utility [patent_app_number] => 12/997234 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 32947 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069612 [patent_doc_number] => 09107946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Drug combinations comprising a DGAT inhibitor and a PPAR-agonist' [patent_app_type] => utility [patent_app_number] => 12/993491 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 43798 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6203020 [patent_doc_number] => 20110065806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'EMOLLIENT COMPOSITION FOR THE PREVENTIVE TREATMENT OF ATOPIC DERMATITIS' [patent_app_type] => utility [patent_app_number] => 12/992666 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5448 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065806.pdf [firstpage_image] =>[orig_patent_app_number] => 12992666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978323 [patent_doc_number] => 20110071226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'EMOLLIENT COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/992808 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4396 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071226.pdf [firstpage_image] =>[orig_patent_app_number] => 12992808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5978087 [patent_doc_number] => 20110071166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'MEDICINE CONSISTING OF CONCOMITANT USE OR COMBINATION OF DPP-IV INHIBITOR AND OTHER DIABETIC MEDICINE' [patent_app_type] => utility [patent_app_number] => 12/988541 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5327 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071166.pdf [firstpage_image] =>[orig_patent_app_number] => 12988541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929988 [patent_doc_number] => 20110039947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'SURFACE-MODIFIED NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 12/989432 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12882 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039947.pdf [firstpage_image] =>[orig_patent_app_number] => 12989432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944839 [patent_doc_number] => 20110105459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'AZETIDINES AND CYCLOBUTANES AS HISTAMINE H3 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/991225 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61880 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105459.pdf [firstpage_image] =>[orig_patent_app_number] => 12991225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113177 [patent_doc_number] => 08569349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 12/991435 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14444 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12991435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413717 [patent_doc_number] => 08697754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Aminoalcohol and biocide compositions for aqueous based systems' [patent_app_type] => utility [patent_app_number] => 12/988404 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4891 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059951 [patent_doc_number] => 08546386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Corrosion and microbial control in hydrocarbonaceous compositions' [patent_app_type] => utility [patent_app_number] => 12/988550 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9062 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039199 [patent_doc_number] => 09079897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors' [patent_app_type] => utility [patent_app_number] => 12/935405 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14028 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12935405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505306 [patent_doc_number] => 09233165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Oligomer-aryloxy-substituted propanamine conjugates' [patent_app_type] => utility [patent_app_number] => 12/936894 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16978 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6008020 [patent_doc_number] => 20110060051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 12/991524 [patent_app_country] => US [patent_app_date] => 2009-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11960 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060051.pdf [firstpage_image] =>[orig_patent_app_number] => 12991524 [rel_patent_id] =>[rel_patent_doc_number] =>)